Nanosonics Updates Progress of On-Market Share Buy-Back

An announcement from Nanosonics Limited ( (AU:NAN) ) is now available.

Nanosonics Limited, the ASX-listed infection prevention technology company, continues to focus on its core medical device and disinfection markets, where it supplies solutions to healthcare providers globally. The company’s securities trade under the code NAN as ordinary fully paid shares on the Australian Securities Exchange.

The company has provided an updated notification of its on-market share buy-back, reporting that a total of 3,652,495 shares had been repurchased before the previous trading day, with a further 1,862 shares bought back on that day. This ongoing buy-back program, first notified in December 2025 and now updated as of 27 March 2026, signals continued capital management efforts that may support earnings per share and reflect management’s confidence in Nanosonics’ valuation and long-term strategy.

The most recent analyst rating on (AU:NAN) stock is a Buy with a A$5.55 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.

More about Nanosonics Limited

Nanosonics Limited is an Australian-listed medical technology company trading under the ASX code NAN. The company is known for its infection prevention solutions and related devices, operating in the healthcare sector and serving hospitals and clinical settings focused on high-level disinfection needs.

Average Trading Volume: 652,625

Technical Sentiment Signal: Sell

Current Market Cap: A$1.1B

For an in-depth examination of NAN stock, go to TipRanks’ Overview page.